1. Market Research
  2. > Pharmaceutical Market Trends

Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry

  • January 2014
  • 56 pages
  • Frost & Sullivan
Report ID: 1963441

Summary

Table of Contents

Increasing Volume and Decreasing Value

Objectives of the Study

Rationale for M&As

The challenges posed by expiring patents, the global economic slowdown, generic competition, reduced healthcare spending, and price premium pressures are forcing the pharma and biotech industry to restructure and streamline strategies to increase profitability. M&As have become key for the reversal of reduced profitability by opening access to new markets while creating more revenue pools and to some extent compensating for the depletion of the R&D pipeline.

Key Trends

- Big pharma’s contribution to M&A deal value has been decreasing, unlocking big pharma’s inability to participate in high-value deals over the past few years.
- The trend of increasing low-value deals is expected to continue. However, big pharma’s balance sheets show signs of a few mega deals.
- North America remains the most active region in terms of both number and value of deals.
- The pharmaceutical and biotechnology stock market indices continue to outperform the S&P 500 index.
- Biotechnology deals witnessed higher stock premiums compared to the pharmaceutical sector.
- Horizontal integration remains key in both the pharmaceutical and biotechnology sectors.

Key Terms Used in the Study

Transactions
- M&A: Mergers and acquisitions is an aspect of corporate strategy, corporate finance, and management by which corporations legally unify ownership of assets formerly subject to separate controls. The term “deal” in the study refers to M&A transactions.
- The Industry is comprised of 2 sectors, pharmaceutical and biotechnology.

Sector
- Pharmaceutical: Companies engaged in the research, development, or production of pharmaceuticals.
- Biotechnology: Companies primarily engaged in the research, development, manufacture, and/or marketing of products based on genetic analysis and genetic engineering. This includes companies specializing in protein-based therapeutics to treat human diseases.

Big Pharma
The collective term referring to the largest participants in terms of revenue in the pharmaceutical sector. The list of companies included in this study is provided in the glossary.

Big Biotech
The collective term referring to the largest participants in terms of revenue in the biotechnology sector. The list of companies included in this study is provided in the glossary.

Study’s Key Objectives Include:
- Analyzing the mergers and acquisitions (M&A) trends in the global pharma and biotech industry
- Identifying the key M&A trends in the industry based on geographies, deals across sectors, and the natures of buyers
- Conducting a financial analysis of the deals with respect to valuation multiples
- Identifying, comparing, and assessing geographical regions that have current and potential M&A activity
- To arrive at strategic conclusions based on the key trends observed

Analysis Includes

- Across sectors
- Across geographies
- Valuation multiples
- Stock price variations
- Percentage of stake acquired
- Type of buyers

Who will benefit?

- Companies operating in the global pharma and biotech industry
- Private equity
- Venture capital investors
- Fund managers
- Retail investors
- Sovereign wealth funds
- Hedge funds
- Insurance funds and other members in the investing community

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Pharmaceutical, Laboratory and Hygienic Glassware Markets in the World to 2021 - Market Size, Trends, and Forecasts

  • $ 26587
  • Industry report
  • July 2017
  • by Global Research & Data Services

This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for pharmaceutical, laboratory and hygienic glassware in the world. Along ...

PharmaPoint: Chronic Obstructive Pulmonary Disease - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • May 2017
  • by GlobalData

PharmaPoint: Chronic Obstructive Pulmonary Disease - Global Drug Forecast and Market Analysis to 2025 Summary COPD is a progressive lung disease characterized by an abnormal inflammatory response and airflow ...

OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026

  • $ 10995
  • Industry report
  • May 2017
  • by GlobalData

OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026 Summary Nonalcoholic steatohepatitis (NASH) (ICD-10-CM = K75.81) is a condition that develops as a subgroup of nonalcoholic fatty ...


Download Unlimited Documents from Trusted Public Sources

Pharmaceutical Statistics in Europe

  • August 2017
    13 pages
  • Pharmaceutical  

    Pharmacy  

  • Europe  

    United Kingdom  

    World  

View report >

Pharmaceutical Industry in India

  • August 2017
    7 pages
  • Pharmaceutical  

  • India  

    Asia  

    United Kingdom  

View report >

Global Pharmaceutical Forecast

  • August 2017
    6 pages
  • Pharmaceutical  

  • United States  

    World  

View report >

Opioid Market

7 days ago

Related Market Segments :

Pharmaceutical

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.